You are here

  • Home
  • Archive
  • Volume 77, Issue 2
  • The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy

Article info

Article menu
Download PDFPDF
Viewpoint
The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy

Authors

  • Leonard Calabrese Department of Rheumatology/Immunology, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles
  • Xavier Mariette Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France Université Paris-Sud, Le Kremlin Bicêtre, France IMVA Center, INSERM, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Leonard Calabrese, Department of Rheumatology/Immunology, Cleveland Clinic, Cleveland, OH 44195, USA; calabrl{at}ccf.org
View Full Text

Citation

Calabrese L, Mariette X
The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy
Annals of the Rheumatic Diseases 2018;77:162-164.

Publication history

  • Received July 12, 2017
  • Revised September 5, 2017
  • Accepted September 8, 2017
  • First published September 19, 2017.
Online issue publication 
July 16, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.